JP2024523401A - コピー数情報に基づく組織起源分析のための方法および組成物 - Google Patents

コピー数情報に基づく組織起源分析のための方法および組成物 Download PDF

Info

Publication number
JP2024523401A
JP2024523401A JP2023577904A JP2023577904A JP2024523401A JP 2024523401 A JP2024523401 A JP 2024523401A JP 2023577904 A JP2023577904 A JP 2023577904A JP 2023577904 A JP2023577904 A JP 2023577904A JP 2024523401 A JP2024523401 A JP 2024523401A
Authority
JP
Japan
Prior art keywords
dna
target regions
specific
cancer
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023577904A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022271730A5 (https=
JP2024523401A5 (https=
Inventor
アンドリュー ケネディ,
Original Assignee
ガーダント ヘルス, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ガーダント ヘルス, インコーポレイテッド filed Critical ガーダント ヘルス, インコーポレイテッド
Publication of JP2024523401A publication Critical patent/JP2024523401A/ja
Publication of JPWO2022271730A5 publication Critical patent/JPWO2022271730A5/ja
Publication of JP2024523401A5 publication Critical patent/JP2024523401A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855Ligating adaptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2023577904A 2021-06-21 2022-06-21 コピー数情報に基づく組織起源分析のための方法および組成物 Pending JP2024523401A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163213050P 2021-06-21 2021-06-21
US63/213,050 2021-06-21
PCT/US2022/034382 WO2022271730A1 (en) 2021-06-21 2022-06-21 Methods and compositions for copy-number informed tissue-of-origin analysis

Publications (3)

Publication Number Publication Date
JP2024523401A true JP2024523401A (ja) 2024-06-28
JPWO2022271730A5 JPWO2022271730A5 (https=) 2025-06-30
JP2024523401A5 JP2024523401A5 (https=) 2025-06-30

Family

ID=82655348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023577904A Pending JP2024523401A (ja) 2021-06-21 2022-06-21 コピー数情報に基づく組織起源分析のための方法および組成物

Country Status (4)

Country Link
US (1) US20240263241A1 (https=)
EP (1) EP4359562A1 (https=)
JP (1) JP2024523401A (https=)
WO (1) WO2022271730A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202308392D0 (en) * 2023-06-06 2023-07-19 Fu Guoliang Methods, compositions, and kits for preparing library and targeted sequencing
WO2025076425A1 (en) * 2023-10-06 2025-04-10 Guardant Health, Inc. Genomic and methylation biomarkers for prediction of copy number loss / gene deletion

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US20030017081A1 (en) 1994-02-10 2003-01-23 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
AU2002359522A1 (en) 2001-11-28 2003-06-10 Applera Corporation Compositions and methods of selective nucleic acid isolation
CA2519860C (en) 2003-03-21 2018-01-16 Santaris Pharma A/S Short interfering rna (sirna) analogues
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
AU2013262435B2 (en) * 2012-05-18 2019-03-07 Clinical Genomics Pty. Ltd. A method of screening for colorectal cancer
US9116118B2 (en) 2012-06-08 2015-08-25 Pacific Biosciences Of California, Inc. Modified base detection with nanopore sequencing
GB2533006B (en) 2012-09-04 2017-06-07 Guardant Health Inc Systems and methods to detect copy number variation
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
IL305462A (en) 2015-07-23 2023-10-01 Univ Hong Kong Chinese DNA fragmentation pattern analysis suitable clean
MX2018010362A (es) * 2016-02-29 2019-03-28 Found Medicine Inc Metodos y sistemas para evaluar carga mutacional de tumores.
CN109415763A (zh) * 2016-05-03 2019-03-01 大学健康网络 捕获无细胞的甲基化dna的方法及其用途
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
CA3046007A1 (en) 2016-12-22 2018-06-28 Guardant Health, Inc. Methods and systems for analyzing nucleic acid molecules
US20230272474A1 (en) * 2018-01-19 2023-08-31 The University Of North Carolina At Chapel Hill Methylation markers for melanoma and uses thereof
CN112703254A (zh) 2018-07-23 2021-04-23 香港中文大学 游离dna损伤分析及其临床应用
JP7466519B2 (ja) * 2018-07-23 2024-04-12 ガーダント ヘルス, インコーポレイテッド 腫瘍遺伝子変異量を腫瘍割合およびカバレッジによって調整するための方法およびシステム
EP4524263A3 (en) * 2018-10-31 2025-05-28 Guardant Health, Inc. Methods, compositions and systems for calibrating epigenetic partitioning assays
EP4567131A3 (en) * 2019-01-31 2025-09-03 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
US11891653B2 (en) * 2019-09-30 2024-02-06 Guardant Health, Inc. Compositions and methods for analyzing cell-free DNA in methylation partitioning assays
EP4200437A4 (en) 2020-08-18 2025-07-23 Delfi Diagnostics Inc METHODS AND SYSTEMS FOR SIZE-BASED DENSITIES OF CELL-FREE DNA FRAGMENTS TO ASSESS CANCER

Also Published As

Publication number Publication date
WO2022271730A1 (en) 2022-12-29
EP4359562A1 (en) 2024-05-01
WO2022271730A9 (en) 2023-12-14
US20240263241A1 (en) 2024-08-08

Similar Documents

Publication Publication Date Title
JP7717057B2 (ja) メチル化分配アッセイにおいて無細胞dnaを解析するための組成物および方法
US20260022424A1 (en) Nucleic acid methylation profiling method
US20240191290A1 (en) Methods for detection and reduction of sample preparation-induced methylation artifacts
JP2023551292A (ja) メチル化されたポリヌクレオチドを富化するための組成物および方法
US20240229113A1 (en) Methods and compositions for detecting nucleic acid variants
US20250236916A1 (en) Enrichment of aberrantly modified dna
US20250101494A1 (en) Methods for analyzing cytosine methylation and hydroxymethylation
US20250084464A1 (en) Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
WO2023122623A1 (en) Methods and systems for combinatorial chromatin-ip sequencing
US20240263241A1 (en) Methods and compositions for copy-number informed tissue-of-origin analysis
US20240093292A1 (en) Quality control method
WO2024073508A2 (en) Methods and compositions for quantifying immune cell dna
WO2024229143A1 (en) Quality control method for enzymatic conversion procedures
JP2025542261A (ja) 統合された対象および全ゲノム体細胞およびdnaメチル化シーケンシングワークフロー
WO2022204730A1 (en) Methods and compositions for quantifying immune cell dna
WO2024229433A1 (en) Methods for analysis of dna methylation
JP2024520422A (ja) 循環分子をアッセイするための組成物および方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250620